|
López-Cuenca Á, Manzano-Fernández S, Marín F, Parra-Pallares S, Navarro-Peñalver M, Montalban-Larrea S, Andreu-Cayuelas JM, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Januzzi JL Jr. Beta-trace protein and cystatin c as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome. Circ J. 2013;77(8):2088-96. PubMed PMID: 23698027.
AÑO: 2013; IF: 3.685
|
23698027
|
Montoro-García S, Orenes-Piñero E, Marín F, Mariano, Valdés, Lip GY, Shantsila E. Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders. Curr Pharm Des. 2012;18(6):840-9. Review. PubMed PMID: 22288445.
AÑO: 2012; IF: 3.311
|
|
Orenes-Piñero E, Hernández-Romero D, Romero-Aniorte AI, Martínez M, García-Honrubia A, Caballero L, Garrigos-Gómez N, Andreu-Cayuelas JM, González J, Feliu E, Climent V, Nicolás-Ruiz F, De La Morena G, Valdés M, Lip GY, Marín F. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM. 2014 Aug;107(8):613-21. doi: 10.1093/qjmed/hcu046. PubMed PMID: 24599807.
AÑO: 2014; IF: 2.495
|
|
Roldán V, Arroyo AB, Salloum-Asfar S, Manzano-Fernández S, García-Barberá N, Marín F, Vicente V, González-Conejero R, Martínez C. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation. Thromb Haemost. 2014 Oct;112(4):781-8. doi: 10.1160/TH14-01-0092. PubMed PMID: 25008481.
AÑO: 2014; IF: 4.984
|
|
Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy. Eur J Clin Invest. 2015 Feb;45(2):179-86. doi: 10.1111/eci.12394. PubMed PMID: 25524713.
AÑO: 2015; IF: 2.687
|